REGENERON PHARMACEUTICALS INC. - COMMON STOCK

712.40

27-December-24 16:45:00

15 minutes delayed

Stocks

-4.28

-0.60%

Today's range

709.09 - 718.99

ISIN

N/A

Source

NASDAQ

NetDania - New 12 months High: REGENERON PHARMACEUTICALS INC. - COMMON STOCK

20 Aug 2024 09:47:18 By NetDania Notify
NetDania - New 12 months High: REGENERON PHARMACEUTICALS INC. - COMMON STOCK

19 Aug 2024 09:50:04 By NetDania Notify
NetDania - New 12 months High: REGENERON PHARMACEUTICALS INC. - COMMON STOCK

16 Aug 2024 11:58:01 By NetDania Notify
NetDania - New 12 months High: REGENERON PHARMACEUTICALS INC. - COMMON STOCK

15 Aug 2024 09:45:08 By NetDania Notify
NetDania - New 12 months High: REGENERON PHARMACEUTICALS INC. - COMMON STOCK

14 Aug 2024 10:27:20 By NetDania Notify
NetDania - New 12 months High: REGENERON PHARMACEUTICALS INC. - COMMON STOCK

13 Aug 2024 09:50:04 By NetDania Notify
NetDania - New 12 months High: REGENERON PHARMACEUTICALS INC. - COMMON STOCK

09 Aug 2024 09:48:01 By NetDania Notify
Regeneron Announces Investor Conference Presentations and Oncology Investor Webcast

07 Aug 2024 16:05:01 By Nasdaq GlobeNewswire
NetDania - New 12 months High: REGENERON PHARMACEUTICALS INC. - COMMON STOCK

02 Aug 2024 09:46:30 By NetDania Notify
Regeneron Reports Second Quarter 2024 Financial and Operating Results

01 Aug 2024 06:30:00 By Nasdaq GlobeNewswire
Regeneron Announces the 2024 Winners of the Regeneron Prize for Creative Innovation

31 Jul 2024 07:30:00 By Nasdaq GlobeNewswire
NetDania - New 12 months High: REGENERON PHARMACEUTICALS INC. - COMMON STOCK

12 Jul 2024 09:45:06 By NetDania Notify
NetDania - New 12 months High: REGENERON PHARMACEUTICALS INC. - COMMON STOCK

11 Jul 2024 10:10:53 By NetDania Notify
Dupixent® (dupilumab) Approved in the European Union as the First-ever Targeted Therapy for Patients with COPD

03 Jul 2024 01:00:00 By Nasdaq GlobeNewswire
Odronextamab Recommended for EU Approval by the CHMP to Treat Relapsed/Refractory Follicular Lymphoma and Diffuse Large B-cell Lymphoma

28 Jun 2024 07:00:00 By Nasdaq GlobeNewswire
Regeneron to Report Second Quarter 2024 Financial and Operating Results and Host Conference Call and Webcast on August 1, 2024

27 Jun 2024 16:05:00 By Nasdaq GlobeNewswire
Dupixent® (dupilumab) Positive Phase 3 Data in Children 1 to 11 Years of Age with Eosinophilic Esophagitis Published in the New England Journal of Medicine

26 Jun 2024 17:30:00 By Nasdaq GlobeNewswire
NetDania - New 12 months High: REGENERON PHARMACEUTICALS INC. - COMMON STOCK

25 Jun 2024 09:45:03 By NetDania Notify
NetDania - New 12 months High: REGENERON PHARMACEUTICALS INC. - COMMON STOCK

24 Jun 2024 09:56:19 By NetDania Notify
NetDania - New 12 months High: REGENERON PHARMACEUTICALS INC. - COMMON STOCK

21 Jun 2024 10:29:52 By NetDania Notify

<<
<
1
2
3
>

I Agree NetDania's website uses cookies. By continuing browsing our website, you agree to our Cookie Policy, Privacy Policy and Terms and Conditons.